The medical device winner just keeps on winning.
News & Analysis: DexCom
DXCM earnings call for the period ending September 30, 2019.
Which stock wins in a battle between these two continuous glucose monitoring system leaders?
This medical device stock is on a roll. But can its sizzling momentum continue?
The charts for these three stocks show the kinds of curves that investors should really like -- trending upward.
These medical device stocks appear to have what it takes to be long-term winners.
The medical device maker delivered strong revenue and adjusted earnings growth in Q2 thanks to continued popularity of its G6 continuous glucose monitoring system.
DXCM earnings call for the period ending June 30, 2019.
These three medtech companies are at the forefront of diabetes care.
Good news for the company's G6 CGM system translated to a nice gain.